ArticleNature2020
Are we ready for a new era of high-impact and high-frequency epidemics?
Article in Nature, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Preferential Tax Policies: An Invisible Hand behind Preparedness for Public Health Emergencies.International journal of health policy and management · 2022Article
- Spatial technologies to strengthen traditional testing for SARS-CoV-2.Trends in microbiology · 2021Article
- Addressing Biodisaster X Threats With Artificial Intelligence and 6G Technologies: Literature Review and Critical Insights.Journal of medical Internet research · 2021Review
- Spatiobehavioral Characteristics - Defining the Epidemiology of New Contagious Diseases at the Earliest Moment Possible.Trends in parasitology · 2021Article
- An extended Weight Kernel Density Estimation model forecasts COVID-19 onset risk and identifies spatiotemporal variations of lockdown effects in China.Communications biology · 2021Article
- Early warning of epidemics: towards a national intelligent syndromic surveillance system (NISSS) in China.BMJ global health · 2020Article
- Article
- Biosafety threats of the rapidly established labs for SARS-CoV-2 tests in China.Environment international · 2020Article
Corrections and comments
- Comment on
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
32286555What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.